Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T59929 | ||||
Target Name | Thymidine phosphorylase (TYMP) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | 1-(cyclohexyl)methyl-5'-O-tritylinosine | Drug Info | IC50 = 4400 nM | [2] | |
1-(cyclopropyl)methyl-5'-O-tritylinosine | Drug Info | IC50 = 2300 nM | [2] | ||
1-allyl-5'-O-tritylinosine | Drug Info | IC50 = 11000 nM | [2] | ||
1-benzyl-5'-O-tritylinosine | Drug Info | IC50 = 11000 nM | [2] | ||
1-propyl-5'-O-tritylinosine | Drug Info | IC50 = 13000 nM | [2] | ||
5-benzyl-6-chloropyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 4550 nM | [4] | ||
5-bromo-6-(cyclopropylamino)uracil hydrochloride | Drug Info | IC50 = 7400 nM | [1] | ||
5-bromo-6-hydrazinouracil hydrochloride | Drug Info | IC50 = 4300 nM | [1] | ||
5-butyl-6-chloropyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 1650 nM | [4] | ||
5-chloro-6-hydrazinouracil hydrochloride | Drug Info | IC50 = 4300 nM | [1] | ||
5-fluoro-6-[(2-aminoimidazol-1-yl)methyl]uracil | Drug Info | Ki = 17 nM | [5] | ||
6-amino-5-bromouracil | Drug Info | IC50 = 6800 nM | [3] | ||
6-amino-5-chlorouracil hydrochloride | Drug Info | IC50 = 8300 nM | [1] | ||
6-bromo-5-phenylpyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 1210 nM | [4] | ||
6-chloro-5-(2-thienyl)pyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 540 nM | [4] | ||
6-chloro-5-heptylpyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 1600 nM | [4] | ||
6-chloro-5-hexylpyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 1790 nM | [4] | ||
6-chloro-5-pentylpyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 3090 nM | [4] | ||
6-chloro-5-phenylpyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 430 nM | [4] | ||
6-chloro-5-propylpyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 4020 nM | [4] | ||
6-fluoro-5-phenylpyrimidine-2,4(1H,3H)-dione | Drug Info | Ki = 470 nM | [4] | ||
References | |||||
REF 1 | Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1335-7. | ||||
REF 2 | 5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase. J Med Chem. 2006 Sep 7;49(18):5562-70. | ||||
REF 3 | Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitors. Eur J Med Chem. 2008 Jun;43(6):1248-60. | ||||
REF 4 | Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase. J Med Chem. 2007 Nov 29;50(24):6016-23. | ||||
REF 5 | The role of phosphate in the action of thymidine phosphorylase inhibitors: Implications for the catalytic mechanism. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1648-51. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.